Maravai LifeSciences Holdings, (MRVI) Financials
MRVI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.5 billion | 697.6 million |
| 2023-09-30 | 2.3 billion | 1.4 billion |
| 2023-06-30 | 2.3 billion | 1.4 billion |
| 2023-03-31 | 2.3 billion | 1.4 billion |
MRVI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -9.0 million | 9.3 million |
| 2023-09-30 | -1.7 million | 10.0 million |
| 2023-06-30 | -5.9 million | 9.3 million |
| 2023-03-31 | 77.2 million | 6.0 million |
MRVI Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | -106.0 million |
| 2023-09-30 | -6.5 million |
| 2023-06-30 | -11.9 million |
| 2023-03-31 | -1.3 million |
MRVI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 575.0 million | - | 86.8 million |
| 2023-09-30 | 579.6 million | - | 89.7 million |
| 2023-06-30 | 580.2 million | 520.3 million | 91.5 million |
| 2023-03-31 | 628.3 million | 521.2 million | 89.7 million |
MRVI Shares Outstanding
MRVI Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 16.8 million | 4.6 million | 38.5 million | - |
| 2023-09-30 | 15.8 million | 4.3 million | 38.9 million | - |
| 2023-06-30 | 25.1 million | 4.2 million | 35.4 million | - |
| 2023-03-31 | 7.9 million | 4.1 million | 38.7 million | - |
MRVI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 74.1 million | 35.7 million |
| 2023-09-30 | 66.9 million | 36.7 million |
| 2023-06-30 | 68.9 million | 43.3 million |
| 2023-03-31 | 79.0 million | 33.7 million |
MRVI
Price: $9
52 week price:
Earnings Per Share: -0.90 USD
P/E Ratio: 30.44
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Market Capitalization: 2.0 billion